[Septic abscess-forming pneumonia with osseous and hepatic involvement caused by Streptococcus intermedius].
Guehring
T
T
Herrmann
M J
MJ
Kiessling
F
F
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001999:Bronchoscopy; D002443:Ceftriaxone / Q000627:therapeutic use; D003937:Diagnosis, Differential; D015299:Discitis / Q000209:etiology*; D005500:Follow-Up Studies; D006801:Humans; D008100:Liver Abscess / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D008169:Lung Abscess / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D018410:Pneumonia, Bacterial / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D013902:Radiography, Thoracic; D013290:Streptococcal Infections / Q000188:drug therapy; D034367:Streptococcus intermedius / Q000302:isolation & purification; D013997:Time Factors; D014057:Tomography, X-Ray Computed
D000900:Anti-Bacterial Agents; D002443:Ceftriaxone